ARTICLE | Clinical News
Enclomiphene citrate regulatory update
December 7, 2015 8:00 AM UTC
FDA issued a complete response letter to Repros for enclomiphene to treat secondary hypogonadism in overweight men wishing to restore normal testicular function. According to Repros, FDA stated that “...